Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management

Published:2022-01 Issue: Volume:154 Page:116202
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Schaefer Benedikt,Tobiasch Moritz,Wagner Sonja,Glodny Bernhard,Tilg Herbert,Wolf Myles,Zoller Heinz

Funder

Medizinische Universität Innsbruck

Gilead Sciences

Merck Sharp and Dohme

Novartis

Christian Doppler Forschungsgesellschaft

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference45 articles.

1. Iron deficiency;Pasricha;Lancet,2021

2. Iron-deficiency anemia;Camaschella;N. Engl. J. Med.,2015

3. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications;Jahn;Eur. J. Pharm. Biopharm.,2011

4. Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose;Neiser;Biometals,2015

5. Structure/histotoxicity relationship of parenteral iron preparations;Geisser;Arzneimittelforschung,1992

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron homeostasis in obesity and metabolic and bariatric surgery: a narrative review;Surgery for Obesity and Related Diseases;2024-08

2. Intravenous ferric carboxymaltose is associated with lowering of plasma phosphate levels in patients with gastric bypass surgery: a retrospective case series;Swiss Medical Weekly;2024-07-24

3. A Cost-utility Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China;2024-07-11

4. Management of Iron Deficiency in Heart Failure;JACC: Heart Failure;2024-07

5. Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease;Quality of Life Research;2024-06-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3